These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37154257)

  • 1. Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran.
    Mohamadzadeh D; Assar S; Pournazari M; Soufivand P; Soleymani MS
    Reumatismo; 2023 May; 75(1):. PubMed ID: 37154257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence and cost-related medication non-adherence in patients with rheumatoid arthritis: A cross-sectional study.
    Heidari P; Cross W; Weller C; Nazarinia M; Crawford K
    Int J Rheum Dis; 2019 Apr; 22(4):555-566. PubMed ID: 30924291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
    Marras C; Monteagudo I; Salvador G; de Toro FJ; Escudero A; Alegre-Sancho JJ; Raya E; Ortiz A; Carmona L; Mestre Y; Cea-Calvo L; Calvo-Alén J
    Rheumatol Int; 2017 Jul; 37(7):1195-1202. PubMed ID: 28516236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of methotrexate adherence in rheumatoid arthritis patients.
    De Cuyper E; De Gucht V; Maes S; Van Camp Y; De Clerck LS
    Clin Rheumatol; 2016 May; 35(5):1335-9. PubMed ID: 26781783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile Phone Text Messages and Effect on Treatment Adherence in Patients Taking Methotrexate for Rheumatoid Arthritis: A Randomized Pilot Study.
    Mary A; Boursier A; Desailly Henry I; Grados F; Séjourné A; Salomon S; Fardellone P; Brazier M; Goëb V
    Arthritis Care Res (Hoboken); 2019 Oct; 71(10):1344-1352. PubMed ID: 30192070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
    Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
    RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High degree of nonadherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Rauscher V; Englbrecht M; van der Heijde D; Schett G; Hueber AJ
    J Rheumatol; 2015 Mar; 42(3):386-90. PubMed ID: 25593229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonadherence to disease modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patients.
    Pasma A; den Boer E; van 't Spijker A; Timman R; van den Bemt B; Busschbach JJ; Hazes JM
    Rheumatology (Oxford); 2016 Oct; 55(10):1812-9. PubMed ID: 27354686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.
    van den Bemt BJ; van den Hoogen FH; Benraad B; Hekster YA; van Riel PL; van Lankveld W
    J Rheumatol; 2009 Oct; 36(10):2164-70. PubMed ID: 19723906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Monchablon C; Gondé H; Pouplin S; Varin R; Vittecoq O; Lequerré T
    Clin Rheumatol; 2020 Jan; 39(1):207-216. PubMed ID: 31768668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive validity of the 5-item Compliance Questionnaire for Rheumatology (CQR5) in detecting poor adherence of patients with rheumatoid arthritis to biological medication.
    Salaffi F; Di Carlo M; Carotti M; Ceccarelli L; Farah S; Marotto D; Giorgi V; Sarzi-Puttini P
    Arthritis Res Ther; 2020 Sep; 22(1):227. PubMed ID: 32993788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-third of patients are low-adherent to methotrexate for rheumatoid arthritis at the initiation of a first biologic. A cross-sectional study investigating adherence rate and factors.
    Beauvais C; Pau D; Hautin-Monteil V; Ducrot MC; Veerabudun K; Flipo RM
    Joint Bone Spine; 2020 Dec; 87(6):668-669. PubMed ID: 32445934
    [No Abstract]   [Full Text] [Related]  

  • 13. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate.
    Hope HF; Hyrich KL; Anderson J; Bluett J; Sergeant JC; Barton A; Cordingley L; Verstappen SMM;
    Rheumatology (Oxford); 2020 Jan; 59(1):213-223. PubMed ID: 31302692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and Prediction of Adherence to Methotrexate Using Three Self-Report Questionnaires in Patients with Rheumatoid Arthritis.
    Ceranic J; Kisic Tepavcevic D; Petronijevic M; Milic M; Ceranic M; Rancic N; Ristic G
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629736
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort.
    Wabe NT; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee AT; Spargo LD; Metcalf RG; Hall C; Proudman SM; Wiese MD
    J Rheumatol; 2016 Sep; 43(9):1643-9. PubMed ID: 27422892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial.
    Pouls BPH; Bekker CL; Gundogan F; Hebing RC; van Onzenoort HA; van de Ven LI; Vonkeman HE; Tieben R; Vriezekolk JE; van Dulmen S; Van den Bemt B
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36410776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial.
    Kuusalo L; Puolakka K; Kautiainen H; Blåfield H; Eklund KK; Ilva K; Kaipiainen-Seppänen O; Karjalainen A; Korpela M; Valleala H; Leirisalo-Repo M; Rantalaiho V;
    Scand J Rheumatol; 2015; 44(6):449-55. PubMed ID: 26324784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine. A prospective cohort study.
    de Thurah A; Nørgaard M; Harder I; Stengaard-Pedersen K
    Rheumatol Int; 2010 Sep; 30(11):1441-8. PubMed ID: 19823840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.
    de Klerk E; van der Heijde D; Landewé R; van der Tempel H; van der Linden S
    J Rheumatol; 2003 Nov; 30(11):2469-75. PubMed ID: 14677194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.